The Audiological Follow-Up of Children with Symptomatic Congenital Cytomegalovirus Infection: An Experience in Two Italian Centers.
congenital cytomegalovirus infection
healthcare policy
hearing loss
late-onset hearing loss
Journal
Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936
Informations de publication
Date de publication:
30 Jun 2023
30 Jun 2023
Historique:
received:
17
05
2023
revised:
22
06
2023
accepted:
28
06
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Congenital cytomegalovirus (cCMV) infection is the leading cause of non-hereditary sensorineural hearing loss in children. While about 10% of children reportedly display symptoms at birth, 85-90% of cCMV infection cases are asymptomatic. However, 10-15% of these asymptomatic infants may later develop hearing, visual, or neurodevelopmental impairments. This study aimed to evaluate the impact of cCMV infection on newborns' hearing function with a particular emphasis on progressive and late-onset cases. This study is a retrospective chart analysis with longitudinal character and was conducted in two Italian centers: Center 1 (from 1 November 2007 to 31 December 2021) and Center 2 (from 1 January 2012 to 31 December 2021). Data collected included newborn hearing screening results, characterization of hearing loss (unilateral/bilateral, degree of impairment), and audiological follow-up. The cohort consisted of 103 children (42% males, 58% females). In total, 28 children presented with hearing impairment; 71.4% (20 out of 28) of the cases of hearing loss were severe/profound, with 35.7% of the cases due to unilateral hearing loss. Out of twenty-eight, six experienced progression of hearing loss and four had late-onset hearing loss. In the absence of universal cCMV screening, hearing screening at birth for cCMV remains a critical factor for early diagnosis. A significant percentage of children affected by cCMV with normal audiological evaluations at birth is easily lost to follow-up. Close collaboration between neonatologists, pediatricians, and audiological services is fundamental to ensure timely diagnosis and treatment of cCMV-related hearing loss.
Sections du résumé
BACKGROUND
BACKGROUND
Congenital cytomegalovirus (cCMV) infection is the leading cause of non-hereditary sensorineural hearing loss in children. While about 10% of children reportedly display symptoms at birth, 85-90% of cCMV infection cases are asymptomatic. However, 10-15% of these asymptomatic infants may later develop hearing, visual, or neurodevelopmental impairments. This study aimed to evaluate the impact of cCMV infection on newborns' hearing function with a particular emphasis on progressive and late-onset cases.
METHODS
METHODS
This study is a retrospective chart analysis with longitudinal character and was conducted in two Italian centers: Center 1 (from 1 November 2007 to 31 December 2021) and Center 2 (from 1 January 2012 to 31 December 2021). Data collected included newborn hearing screening results, characterization of hearing loss (unilateral/bilateral, degree of impairment), and audiological follow-up.
RESULTS
RESULTS
The cohort consisted of 103 children (42% males, 58% females). In total, 28 children presented with hearing impairment; 71.4% (20 out of 28) of the cases of hearing loss were severe/profound, with 35.7% of the cases due to unilateral hearing loss. Out of twenty-eight, six experienced progression of hearing loss and four had late-onset hearing loss.
CONCLUSIONS
CONCLUSIONS
In the absence of universal cCMV screening, hearing screening at birth for cCMV remains a critical factor for early diagnosis. A significant percentage of children affected by cCMV with normal audiological evaluations at birth is easily lost to follow-up. Close collaboration between neonatologists, pediatricians, and audiological services is fundamental to ensure timely diagnosis and treatment of cCMV-related hearing loss.
Identifiants
pubmed: 37508638
pii: children10071136
doi: 10.3390/children10071136
pmc: PMC10378266
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Arch Dis Child Fetal Neonatal Ed. 2022 Dec 23;:
pubmed: 36564163
Curr Opin Virol. 2014 Oct;8:109-15
pubmed: 25154343
Rev Med Virol. 2007 Sep-Oct;17(5):355-63
pubmed: 17542052
Rev Med Virol. 2017 Sep 6;:
pubmed: 28876493
Antiviral Res. 2020 Apr;176:104732
pubmed: 32081353
Laryngoscope. 2022 Sep;132 Suppl 11:S1-S24
pubmed: 35302239
J Pathol. 2015 Jan;235(2):288-97
pubmed: 25205255
Eur Arch Otorhinolaryngol. 2023 Jul;280(7):3141-3147
pubmed: 36645498
Ital J Pediatr. 2017 Apr 17;43(1):38
pubmed: 28416012
J Pediatric Infect Dis Soc. 2022 Jan 27;11(1):16-23
pubmed: 34718680
Minerva Pediatr (Torino). 2021 May 31;:
pubmed: 34056891
Cell Mol Immunol. 2015 Mar;12(2):128-38
pubmed: 25132454
Am J Otolaryngol. 2009 May-Jun;30(3):193-202
pubmed: 19410125
Lancet Infect Dis. 2017 Jun;17(6):e177-e188
pubmed: 28291720
Int J Pediatr Otorhinolaryngol. 2023 Feb;165:111446
pubmed: 36657329
Pediatrics. 2014 Nov;134(5):972-82
pubmed: 25349318
JAMA Otolaryngol Head Neck Surg. 2023 Feb 1;149(2):122-130
pubmed: 36580312
Int J Infect Dis. 2014 May;22:44-8
pubmed: 24631522
Ital J Pediatr. 2022 Dec 26;48(1):203
pubmed: 36572905
JAMA Otolaryngol Head Neck Surg. 2014 May;140(5):403-9
pubmed: 24700303
Microorganisms. 2020 May 08;8(5):
pubmed: 32397070
Ital J Pediatr. 2017 Sep 20;43(1):82
pubmed: 28931415
Pediatrics. 2017 Mar;139(3):
pubmed: 28209771
Pediatr Infect Dis J. 2016 Aug;35(8):924-6
pubmed: 27195603
Int J Pediatr Otorhinolaryngol. 2022 Nov 6;163:111376
pubmed: 36370539
Nat Rev Microbiol. 2021 Dec;19(12):759-773
pubmed: 34168328
J Am Acad Audiol. 2023 Mar 27;:
pubmed: 36972678
Ann Ig. 2023 May-Jun;35(3):297-307
pubmed: 35861691
Otol Neurotol. 2018 Aug;39(7):854-864
pubmed: 29912824
Hear Res. 2022 Apr;417:108454
pubmed: 35131579
Pediatrics. 2022 Aug 1;150(2):
pubmed: 35909155
Pediatr Infect Dis J. 1992 Feb;11(2):93-9
pubmed: 1311066
JAMA. 2020 Dec 01;324(21):2195-2205
pubmed: 33258894
Int J Pediatr Otorhinolaryngol. 2022 May;156:111099
pubmed: 35276528
Laryngoscope. 2022 Nov;132(11):2241-2250
pubmed: 35072277
J Virol. 2019 Aug 13;93(17):
pubmed: 31217239
Acta Otorhinolaryngol Ital. 2019 Feb;39(1):40-45
pubmed: 30936577
Pharmacol Ther. 2003 Jun;98(3):269-97
pubmed: 12782241
Microorganisms. 2020 Oct 01;8(10):
pubmed: 33019752
Int J Pediatr Otorhinolaryngol. 2023 Jan;164:111420
pubmed: 36563581
Front Cell Infect Microbiol. 2020 Mar 31;10:130
pubmed: 32296651
Rev Med Virol. 2007 Jul-Aug;17(4):253-76
pubmed: 17579921
Ear Hear. 2020 Aug 03;42(2):373-380
pubmed: 32769435